|

DCC-2812 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Deciphera Pharmaceuticals, LLC1

Indications

  • Castration-resistant Prostate Cancer1
  • Renal Cell Carcinoma1
  • Urothelial Carcinoma1
  • Cancer1

Boston, Massachusetts1 trial

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Dana-Farber Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.